Integra LifeSciences Holdings (IART) announced after the bell Wednesday that it is recalling certain products made in its Anasco, Puerto Rico facility owing to deviations in approved production processes.
The company also slashed its revenue and earnings expectations for the first quarter to reflect the recall as well as product shortages. Integra now expects to report revenues of $194 million to $197 million and adjusted earnings of $0.30 to $0.40 per share. The consensus estimates are for revenues of $204.69 million and EPS of $0.69.
Integra LifeSciences gapped open sharply lower Thursday and is now down 3.36 at $35.02 on above average volume. The stock has dropped to nearly a 10-month low.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.